Skip to content
BIO Events
BIG Summit themes: Resilient investment, MFN threat, patients in the center
The inaugural BIO Investment and Growth (BIG) Summit was a chance for leaders in the biotech industry to catch up on domestic and international policy ...
Read More
Latest News
LATEST STORIES
BIO's View
Poll: U.S. voters want PBM and insurance reform—and strong biotech
Voters see a better path than Most Favored Nation to ensure access and affordability of innovative medicines Eight in 10 American voters would be more ...
Health
BIO Board member advises Congress on China’s clinical trial competition
China gains a huge advantage in biotech competition by speeding up clinical trials, and America must respond, a member of the Board of the Biotechnology ...
Editors' Choice
SBIR reauthorization, a top BIO priority, is passed by Congress
Reauthorization of federal seed funding, a top priority for BIO’s work with Congress, passed the House with hefty bipartisan support on March 17 and is ...
WHAT YOU MISSED AT THE LATEST BIO EVENTS
BIG Summit themes: Resilient investment, MFN threat, patients in the center
The inaugural BIO Investment and Growth (BIG) Summit was a chance for leaders in the biotech industry to catch up on domestic and international policy ...
Read More
BIG Summit panel breaks down risks and opportunities coming out of DC
Washington’s healthcare policy landscape is constantly evolving, and 2026 is shaping up to be another consequential year for the biotech industry. Some developments are positive, ...
Read More